Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

被引：0
|
作者：
M. Schena
C. Barone
N. Birocco
D. Dongiovanni
G. Numico
I. Colantonio
O. Bertetto
机构：
[1] Azienda Ospedaliera San Giovanni Battista,Department of Medical Oncology
[2] Ospedale S Croce,Department of Medical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 55卷
关键词：
Palliative chemotherapy; Head and neck cancer; Toxicity; Weekly chemotherapy; Phase II;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：271 / 276
页数：5
相关论文
共 50 条
  • [41] A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Baghi, M
    Hambek, M
    Wagenblast, J
    May, A
    Wolfgang
    Gstoettner
    Knecht, R
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 585 - 590
  • [42] Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer
    Guntinas-Lichius, O
    Appenrodt, S
    Veelken, F
    Krug, B
    [J]. LARYNGOSCOPE, 2006, 116 (04): : 613 - 618
  • [43] Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck
    Specht, L
    Larsen, SK
    Hansen, HS
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (07) : 845 - 849
  • [44] PHASE-I STUDY OF PACLITAXEL, CISPLATIN, AND IFOSFAMIDE IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    BENNER, SE
    LIPPMAN, SM
    HUBER, MH
    HONG, WK
    [J]. SEMINARS IN ONCOLOGY, 1995, 22 (05) : 22 - 25
  • [45] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
  • [46] Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: A multicenter phase II trial
    Gebbia, V
    Mantovani, G
    Agostara, B
    Contu, A
    Farris, A
    Colucci, G
    Cognetti, F
    Restivo, G
    Speciale, R
    Ferrero, B
    Testa, A
    Curreli, L
    Cardinale, A
    Bajetta, E
    Gebbia, N
    [J]. ANNALS OF ONCOLOGY, 1995, 6 (10) : 987 - 991
  • [47] A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, εt 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head εt neck:: a southwest oncology group study
    Worden, F
    Moon, J
    Samlowski, W
    Ensley, J
    Clark, J
    Dakhil, S
    Taylor, S
    Urba, S
    Hussain, M
    [J]. LUNG CANCER, 2004, 46 : S83 - S84
  • [48] A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Dunn, L. A.
    Fury, M. G.
    Xiao, H.
    Baxi, S. S.
    Sherman, E. J.
    Korte, S.
    Pfister, C.
    Haque, S.
    Katabi, N.
    Ho, A. L.
    Pfister, D. G.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (10) : 2533 - 2538
  • [49] Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck (RMHNC).
    Ikpeazu, CV
    Murphy, BA
    Kish, B
    Cmelak, A
    Shyr, Y
    Netterville, J
    Burkey, B
    Chung, C
    Yarbrough, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 508S - 508S
  • [50] A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC)
    Tang, Patricia
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Colevas, A. Dimitrios
    Johnson, Caitlin
    Pond, Greg R.
    Winquist, Eric
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 186 - 186
12345